Sorrento Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
05 Oct 2023	Form 4: Sorrento Therapeutics, Inc., 10% owner · Celularity Inc Sold 9,064,539 shares · Sold 6,307,158 shares
25 Sep 2023	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Sold 60,068,585 shares · Disposed of 4,490,617 Warrants to Purchase Common Stock (Open Market Sale)
20 Mar 2023	Form 4: Ji Henry, Director Received 19,500 shares by exercise ($15.7K) · Disposed of 195 Put Option (obligation to buy) (Disposition to Issuer)
23 Jan 2023	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Disposed of 73,740,795 shares (Other Transaction)
23 Dec 2022	Form 4: Ji Henry, Director Received 200 shares by exercise ($1.1K) · Received 300 shares by exercise ($1.65K)
16 Dec 2022	Form 4: Ji Henry, Director Received 1,500,000 shares as a grant or award
02 Dec 2022	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Acquired 224,841 Warrants to Purchase Common Stock (Open Market Purchase) ($78.9K)
25 Nov 2022	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Acquired 46,172 Warrants to Purchase Common Stock (Open Market Purchase) ($20.2K)
23 Nov 2022	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Acquired 442,829 Warrants to Purchase Common Stock (Open Market Purchase) ($176K)
22 Nov 2022	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Acquired 672,775 Warrants to Purchase Common Stock (Open Market Purchase) ($152K)
15 Nov 2022	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Acquired 3,104,000 Warrant to Purchase Common Stock (Other Transaction)
07 Sep 2022	Form 4: Ji Henry, Director Bought 88,888 shares ($179K) · Acquired 888 Call Option (right to buy) (Open Market Purchase) ($36.2K)
06 Sep 2022	Form 4: Ji Henry, Director Bought 55,555 shares ($109K)
02 Sep 2022	Form 4: Ji Henry, Director Received 2,500,000 shares as a grant or award
26 Aug 2022	Form 4: Ji Henry, Director Bought 33,333 shares ($70.3K) · Disposed of 200 Put Option (obligation to buy) (Open Market Sale) ($69.9K)
25 Aug 2022	Form 4: Ji Henry, Director Bought 22,222 shares ($45.8K) · Acquired 1,000 Call Option (right to buy) (Open Market Purchase) ($30.7K)
14 Jun 2022	Form 4: Ji Henry, Director Bought 10,000 shares ($14K)
20 May 2022	Form 4: Czerepak Elizabeth, EVP & Chief Financial Officer Granted 350,000 Stock Option (right to buy)
20 May 2022	Form 4: Reilly Tammy, Director Granted 100,000 Stock Option (right to buy)
27 Dec 2021	Form 4: Janda Kim, Director Received 3,000 shares by exercise or conversion ($12K) · Sold 3,000 shares ($17.6K)

Comments